跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
iCan Continuous Glucose Monitoring System - Invasive interstitial-fluid glucose monitoring system - TGA Drug Approval Details
Approvals
/
TGA
/
iCan Continuous Glucose Monitoring System - Invasive interstitial-fluid glucose monitoring system
Approved
STANDARD
iCan Continuous Glucose Monitoring System - Invasive interstitial-fluid glucose monitoring system
Qualtech Consulting Corporation Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c7821696920357f7
Company
Qualtech Consulting Corporation Pty Ltd
Type
Standard
Approval Details
Approval Id
c7821696920357f7
Product Name
iCan Continuous Glucose Monitoring System - Invasive interstitial-fluid glucose monitoring system
Artg Id
515190
Artg Name
Qualtech Consulting Corporation Pty Ltd - iCan Continuous Glucose Monitoring System - Invasive interstitial-fluid glucose monitoring system
Sponsor
Qualtech Consulting Corporation Pty Ltd
Artg Date
2025-10-10
Registration Type
Device
Therapeutic Good Type
Medical devices
Licence Status
A
Licence Category
INC
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c7821696920357f7
Type
Standard
Back to TGA Approvals
